Posts for Ticker ‘SNTA’

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data presentations slated to start this weekend.   This is broken down in drug and biotech companies with share values, ranges, and recent developments for the following drug and biotech companies:  Abraxis BioScience, Inc. (NASDAQ:ABII), AEterna Zentaris Inc. (NASDAQ: AEZS), Allos Therapeutics, Inc. (NASDAQ: ALTH), Amgen Inc. (NASDAQ: AMGN), A.P. Pharma, Inc. (Nasdaq: APPA), Arqule Inc. (NASDAQ: ARQL), Bristol-Myers Squibb (NYSE: BMY), Celldex Therapeutics (NASDAQ: CLDX), Celgene Corporation (NASDAQ: CELG), Cell Therapeutics (NASDAQ: CTIC), Cougar Biotechnology, Inc. (NASDAQ: CGRB), Eli Lilly and Company (NYSE: LLY), Exelixis (NASDAQ: EXEL), Genomic Health, Inc. (NASDAQ: GHDX), GlaxoSmithKline (NYSE: GSK) , Immunogen (NASDAQ: IMGN), Medarex (NASDAQ: MEDX), Medivation, Inc. (NASDAQ: MDVN), Micromet, Inc. (NASDAQ: MITI), OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI), OSI Pharmaceuticals (NASDAQ: OSIP), Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), Pfizer Inc. (NYSE: PFE), Rosetta Genomics (NASDAQ:ROSG), Synta Pharmaceuticals (NASDAQ: SNTA), Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN), ZIOPHARM Oncology (NASDAQ: ZIOP), and ZymoGenetics, Inc. (NASDAQ: ZGEN).

The full presentation can be seen at BioHealthInvestor.com.

JON C. OGG
May 27, 2009

Posted on: May 27, 2009 – 1:34 pm in Biotech, Drug companies, FDA, Medical, Pharmaceuticals, , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Previewing 2009 ASCO Abstracts (ABII, ALTH, ARQL, CLDX, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, OGXI, OSIP, PPHM, PFE, SNTA, ZIOP)

We are just about to get the first round of abstracts from companies presenting data at this year’s American Society of Clinical Oncology meeting for 2009.  At BioHealthInvestor.com we compiled a brief summary for companies such as Abraxis BioScience, Inc. (NASDAQ:ABII), Allos Therapeutics, Inc. (NASDAQ: ALTH), Arqule Inc. (NASDAQ: ARQL), Celldex Therapeutics (NASDAQ: CLDX), Cell Therapeutics (NASDAQ: CTIC), Cougar Biotechnology, Inc. (NASDAQ: CGRB), Eli Lilly and Company (NYSE:  LLY), Exelixis (NASDAQ: EXEL), Genomic Health, Inc. (NASDAQ: GHDX), GlaxoSmithKline (NYSE: GSK) , Immunogen (NASDAQ: IMGN), Medarex (NASDAQ: MEDX), Medivation, Inc. (NASDAQ: MDVN), OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI), OSI Pharmaceuticals (NASDAQ: OSIP), Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), Pfizer Inc. (NYSE: PFE), Synta Pharmaceuticals (NASDAQ: SNTA), and ZIOPHARM Oncology (NASDAQ: ZIOP).

You can see that full pre-report here at BiohealthInvestor.com.  As always be advised that there may be new sets of data released between now and the actual meeting from May 29 to June 2, 2009 in Orlando, Florida.

Posted on: May 14, 2009 – 4:56 pm in Biotech, Drug companies, Medical, Pharmaceuticals, , , , , , , , , , , , , , , , , , ,

The 52-Week Low Club (TSCM)(EBAY)(GE)(SNTA)(ABK)(C)

sad_clown16Citigroup (C) Government will take a 36% share. Drops to $1.42 from 52-week high of $27.35.

AMBAC Inc (ABK) Market hates it earnings. Drop to $.56 from 52-week high of $12.37.

Synta Pharmaceuticals (SNTA) Drug trial suspended. Multiple broker downgrades. The daily double. Off to $1.31 from 52-week high of $10.30.

GE (GE) Cuts dividend. Falls to $8.40 from 52-week high of $38.52.

Ebay (EBAY) Concerns recession will hurt e-commerce. Sells down to $10.50 from 52-week high of $33.47.

TheStreet.com (TSCM) Financial advertising falling apart.  Down to $1.87 from 52-week high of $9.49.

Douglas A. McIntyre

Posted on: February 27, 2009 – 3:55 pm in HI/LOW, , , , , ,

Top Pre-Market Analyst Downgrades (ADBE, ADSK, LLNW, NIHD, ORLY, QSFT, SLM, SNTA, USM)

These are the top pre-market analyst downgrades and negative research calls we have seen this Friday morning:

  • Adobe (ADBE) Cut to Market Perform at Wachovia.
  • Autodesk (ADSK) Cut to Hold at KeyBanc.
  • Limelight Networks (LLNW) Cut to Hold at Jefferies.
  • NII Holdings (NIHD) Cut to Neutral at Piper Jaffray.
  • O’Reilly Autoparts (ORLY) Cut to Hold at Deutsche Bank.
  • Quest Software (QSFT) Cut to Market Weight at Thomas Weisel.
  • SLM (SLM) Cut to Equal Weight at Barclays.
  • Synta Pharmaceuticals (SNTA) downgraded at Lazard, Roth Capital, and Wachovia.
  • US Cellular (USM) Cut to Underperform at Baird.

JON C. OGG

Posted on: February 27, 2009 – 8:49 am in Analyst Calls, , , , , , , , ,

Pre-Market Stock News (January 28, 2008)

Alliance Data Systems (ADS) was informed by Blackstone that conditions likely won’t be satisfied to complete the merger; stock trading down close to 40%.
American Express (AXP) reports earnings today with estimates at $0.71 EPS.
Biogen Idec (BIIB) said that Carl Icahn has given notice that he wants to nominate 3 directors to the board.
Black & Decker (BDK) $1.06 EPS vs. $1.03 estimate; lowered guidance for 2008 to $5.40 to 5.90 vs. $6.10+ estimates.
Bluelinx (BXC) now sees wider losses than expected.
Corning (GLW) $0.40 EPS vs. $0.39 estimate; Revenue $1.58B vs. $1.55B est.
eBay (EBAY) announced that PayPal has agreed to acquire Fraud Sciences Ltd. in Israeli for roughly $169 million.
FPL Group (FPL) $0.71 EPS vs. $0.67 estimates.
Halliburton (HAL) $0.74 EPS vs. $0.69 estimates.
Matria Healthcare (MATR) is being acquired by Inverness Medical (IMA) for $39.00 per share, with a breakdown of $6.50 per share in cash and $32.50 per share in convertible preferred stock.
McDonalds (MCD) set to report earnings, estimate $0.71.
Napster (NAPS) announced the launch of the Napster Mobile music service with Ericsson phones at Telecom Italia through its mobile brand TIM.
Sallie Mae (SLM) received commitments for $31 Billion from a consortium of banks led by Bank of America, JPMorgan Chase, Barclays Capital, Deutsche Bank, Credit Suisse, and The Royal Bank of Scotland, and from UBS; new financing will replace the $30 billion interim financing put in place; will drop suit related to past failed merger.
Sears Holdings (SHLD) Aylwin Lewis is stepping down as CEO of Sears.
Stanley Works (SWK) $1.11 EPS vs. $1.10 estimate; reaffirmed 2008 EPS at $4.20 to $4.40 versus $4.37 estimate.
Superior Offshore (DEEP) announced E. Donald Terry will be Interim President/CEO effectively immediately.
Synta (SNTA) and GlaxoSmithKline (GSK) announced elesclomol for metastatic melanoma was granted orphan drug designation by FDA; SNTA trading up 17%.
Ultralife Batteries (ULBI) received $4.4 million in military battery orders from the U.S. Defense Department.
Verizon (VZ) $0.62 EPS vs $0.62 estimate; added 2 million total net wireless customers; now has over 1 million FiOS TV customers.

Jon C. Ogg
January 28, 2008

Posted on: January 28, 2008 – 7:54 am in Pre-Market Activity, , , , , , , , , , , , , , ,